Literature DB >> 15691276

Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation.

Katriina Nikkilä1, Tatu A Miettinen, Krister V A Höckerstedt, Helena Isoniemi.   

Abstract

Serum cholesterol reflects poorly cholesterol metabolism. From serum noncholesterol sterols cholestanol, campesterol, and sitosterol are surrogate markers of cholesterol absorption, but reflect also cholestasis, while those of lathosterol reflect cholesterol synthesis and hepatic parenchymal function. We investigated these sterols at end-stage of primary biliary cirrhosis (PBC) - prior to liver transplantation and shortly after transplantation in 67 patients to show their role as index of cholestasis and parenchymal liver function. Median preoperative values of cholestanol were increased 7.6 times, those of plant sterols 1.6-3.7 times above and the campesterol/sitosterol ratio was decreased twice below our control values, respective lathosterol levels being mainly subnormal. After transplantation, the proportions to cholesterol of the absorption markers decreased, and those of synthesis markers and the ratios of campesterol/sitosterol increased significantly. Thus, surrogate sterol markers of cholesterol absorption and synthesis in serum are also good clinical markers of chronic cholestasis and degree of hepatic parenchymal cell function in PBC. Postoperative improvement of serum sterol profile indicate clinically good function of the liver graft.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691276     DOI: 10.1111/j.1432-2277.2004.00002.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  7 in total

Review 1.  Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.

Authors:  Uwe Christians; Jost Klawitter; Jelena Klawitter; Nina Brunner; Volker Schmitz
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-02       Impact factor: 4.481

Review 2.  Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications.

Authors:  Katriina Nemes; Fredrik Åberg; Helena Gylling; Helena Isoniemi
Journal:  World J Hepatol       Date:  2016-08-08

3.  Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX.

Authors:  M G M de Sain-van der Velden; A Verrips; B H C M T Prinsen; M de Barse; R Berger; G Visser
Journal:  J Inherit Metab Dis       Date:  2008-10-24       Impact factor: 4.982

4.  Circulating sterols as predictors of early allograft dysfunction and clinical outcome in patients undergoing liver transplantation.

Authors:  Uta Ceglarek; Kathleen Kresse; Susen Becker; Georg Martin Fiedler; Joachim Thiery; Markus Quante; Robert Wieland; Michael Bartels; Gabriela Aust
Journal:  Metabolomics       Date:  2016-10-24       Impact factor: 4.290

Review 5.  The Interpretation of Cholesterol Balance Derived Synthesis Data and Surrogate Noncholesterol Plasma Markers for Cholesterol Synthesis under Lipid Lowering Therapies.

Authors:  Frans Stellaard; Dieter Lütjohann
Journal:  Cholesterol       Date:  2017-02-22

6.  A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis.

Authors:  Magdalena Ydreborg; Vera Lisovskaja; Martin Lagging; Peer Brehm Christensen; Nina Langeland; Mads Rauning Buhl; Court Pedersen; Kristine Mørch; Rune Wejstål; Gunnar Norkrans; Magnus Lindh; Martti Färkkilä; Johan Westin
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

7.  Age-related changes of cholestanol and lathosterol plasma concentrations: an explorative study.

Authors:  Monica Gelzo; Maria Donata Di Taranto; Concetta Sica; Antonio Boscia; Francesco Papagni; Giuliana Fortunato; Gaetano Corso; Antonio Dello Russo
Journal:  Lipids Health Dis       Date:  2019-12-30       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.